Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target

[1]  Ling Zhu,et al.  The Long Noncoding RNA ZFAS1 Potentiates the Development of Hepatocellular Carcinoma via the microRNA-624/MDK/ERK/JNK/P38 Signaling Pathway , 2020, OncoTargets and therapy.

[2]  H. Seol,et al.  Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening , 2020, Cancers.

[3]  S. Erdogan,et al.  Inhibition of Midkine Suppresses Prostate Cancer CD133+ Stem Cell Growth and Migration☆,☆☆,★ , 2017, The American journal of the medical sciences.

[4]  C. Lindskog,et al.  A pathology atlas of the human cancer transcriptome , 2017, Science.

[5]  S. Puig,et al.  Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine , 2017, Nature.

[6]  S. Gygi,et al.  The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival , 2017, Nature.

[7]  In-Hee Lee,et al.  Spatiotemporal genomic architecture informs precision oncology in glioblastoma , 2017, Nature Genetics.

[8]  S. Lipton,et al.  Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic Profiling , 2016, Stem cell reports.

[9]  P. Boström,et al.  FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice , 2016, Nature Communications.

[10]  Yanhong Zhang,et al.  Mice deficient in poly(C)-binding protein 4 are susceptible to spontaneous tumors through increased expression of ZFP871 that targets p53 for degradation , 2016, Genes & development.

[11]  Su-Jae Lee,et al.  NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells. , 2016, Cancer research.

[12]  C. Diaconu,et al.  Therapies targeting cancer stem cells: Current trends and future challenges. , 2015, World journal of stem cells.

[13]  S. Cook,et al.  MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road , 2015, Nature Reviews Cancer.

[14]  Xinglian Xu,et al.  Redox Regulation in Cancer Stem Cells , 2015, Oxidative medicine and cellular longevity.

[15]  J. Rich,et al.  Cancer stem cells in glioblastoma , 2015, Genes & development.

[16]  E. Safwat,et al.  The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma , 2015, International journal of hepatology.

[17]  X. Wang,et al.  Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma , 2013, Clinical Cancer Research.

[18]  Yoshikazu Nakamura,et al.  Midkine promotes neuroblastoma through Notch2 signaling. , 2013, Cancer research.

[19]  K. Cibulskis,et al.  Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. , 2012, The Journal of clinical investigation.

[20]  R. Agarwal,et al.  Resveratrol Selectively Induces DNA Damage, Independent of Smad4 Expression, in Its Efficacy against Human Head and Neck Squamous Cell Carcinoma , 2011, Clinical Cancer Research.

[21]  Stephen L. Abrams,et al.  Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging , 2011, Aging.

[22]  B. Meléndez,et al.  Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action , 2011, Cell Death and Differentiation.

[23]  Arata Tomiyama,et al.  Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self‐Renewal and Tumorigenicity of Glioblastoma Stem‐Like Cells , 2010, Stem cells.

[24]  Andreas von Deimling,et al.  Identification of diagnostic serum protein profiles of glioblastoma patients , 2010, Journal of Neuro-Oncology.

[25]  T. Muramatsu.  Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases , 2010, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[26]  James B. Mitchell,et al.  In vitro and In vivo Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor, AZD7762 , 2010, Clinical Cancer Research.

[27]  Shi-Yong Sun.  N-acetylcysteine, reactive oxygen species and beyond , 2010, Cancer biology & therapy.

[28]  Yun Dai,et al.  New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network , 2010, Clinical Cancer Research.

[29]  L. Ellis,et al.  Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology , 2009, Clinical Cancer Research.

[30]  James B. Mitchell,et al.  In Vitro and In Vivo Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor , 2009 .

[31]  H. Fine,et al.  SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. , 2009, Cell stem cell.

[32]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[33]  Stephen Green,et al.  AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies , 2008, Molecular Cancer Therapeutics.

[34]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[35]  M. Berens,et al.  Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. , 2007, Journal of the National Cancer Institute.

[36]  Brad T. Sherman,et al.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.

[37]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[38]  E. Moler,et al.  CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo , 2007, Clinical Cancer Research.

[39]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[40]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[41]  K. Becker,et al.  The Genetic Association Database , 2004, Nature Genetics.

[42]  T. Muramatsu,et al.  Midkine and pleiotrophin in neural development and cancer. , 2004, Cancer letters.

[43]  B. Kaina,et al.  Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. , 2000, Cancer research.

[44]  S. Jackson,et al.  Regulation of p53 in response to DNA damage , 1999, Oncogene.

[45]  Michel Schneider,et al.  UniProtKB/Swiss-Prot. , 2007, Methods in molecular biology.

[46]  C. Hancock.  The long and winding road , 2005, Nature Reviews Drug Discovery.

[47]  Anita B. Roberts,et al.  Autocrine growth factors and cancer , 1985, Nature.